These are published materials from FDA, professional societies and cancer care organizations and grouped by the question they answer. Resources do not represent an endorsement or recommendation. They are intended to be illustrative of available materials and to provide general guidance.
ACCC's quick reference checklist for after care. This checklist covers everything from contact information, monitoring and support needs.
Download (PDF)FDA’s June 2025 notice removing the REMS for autologous CAR T therapies, with the monitoring, proximity and driving parameters that replaced it, and the 15-year follow-up that did not change.
VisitCell and gene therapies in managed care: US payer insights on coverage and financial risks
Download (PDF)Five-Year durability in cell and gene therapy: evidence review and implications for payer coverage.
Download (PDF)A 2024 ACCC brief on why CAR-T reimbursement falls short of cost, covering the NTAP and MS-DRG 018 history, prior authorization delays, Medicaid limits, and fixes like outpatient care.
Download (PDF)A manufacturer-agnostic guide to onboarding a CAR-T treatment center in six stages, from initiation to sustainment.
Download (PDF)The EBMT/EHA CAR-T Cell Handbook has a European focus. Product handling: reception, cryogenic storage, thaw timing, dispensing and administration, and the pharmacist’s role is universal.
Download (PDF)InspiroGene’s 2025 report covers a pipeline moving beyond oncology, a survey of 126 oncologists and interviews with 20 payers on access and reimbursement, and flat growth in treatment sites.
Download (PDF)McKesson’s 2024 report covers a late-stage CGT pipeline of 734 drugs moving beyond oncology, a survey of 124 oncologists on barriers to access, a map of treatment centers, and a call to action.
Download (PDF)“CAR T-Cell Therapy in Action: Successful Examples in Outpatient Settings” profiles outpatient CAR-T at City of Hope, Astera Cancer Care, and St Luke’s Cancer Institute.
Download (PDF)"Advancing Outpatient CAR T-Cell Therapy in the Community: The NYOH Model" building a community outpatient CAR-T program with a hospital partner, covering infrastructure, staffing, product choice, payer contracting, and first 6 patients.
VisitACCC’s profile of how a rural health system stood up a CAR-T program, covering implementation, staff education and communication with referring providers.
Download (PDF)An ACCC profile of how Fox Chase Cancer Center works with community programs such as St. Luke’s to deliver CAR-T, covering onboarding, REMS, coverage, referrals, and patient support.
Download (PDF)“Expanding CAR T-Cell Therapy in Community Oncology” Virginia Cancer Specialists built a community CAR-T program, covering leadership, care pathways, team, hospital partners, payers, and early cases.
VisitExpanding Access to Life-Prolonging Cellular Therapies: A Case Series of the First Three CAR T-cell Recipients at an Urban Public Safety-Net Hospital
VisitThere are many available resources that are reliable and can provide you and your patients with great guidance. Check out some of the available links below.
We’re here to help. Reach out today to connect with experts that can guide you.
